A non-inferiority trial comparing 2 days vs. 5 days of terlipressin and ceftriaxone in terms of 5-day rebleeding for patients with acute gastro-esophageal variceal hemorrhage

Post time 2024-4-18 19:18:15

journal：American Journal of Gastroenterology

Authors：Gin-Ho Lo; Jen-Hao Yeh; Cheng-Hao Tseng; Tzu-Haw Chen; Chi-Ming Tai; Wen-Lun Wang; Hui- Chen Lin

Published date：--

DOI：10.14309/ajg.0000000000002776

PDF link：https://journals.lww.com/10.14309/ajg.0000000000002776

Article link：http://dx.doi.org/10.14309/ajg.0000000000002776

Article Source：Ovid Technologies (Wolters Kluwer Health)。

Remark：

Post time 2024-4-18 19:18:16

: This post has been completed
Completed attachments will be deleted within 24 hours.

[Other] A non-inferiority trial comparing 2 days vs. 5 days of terlipressin and ceftriaxone in terms of 5-day rebleeding for patients with acute gastro-esophageal variceal hemorrhage

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today

[Other] A non-inferiority trial comparing 2 days vs. 5 days of terlipressin and ceftriaxone in terms of 5-day rebleeding for patients with acute gastro-esophageal variceal hemorrhage Copy

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today

[Other] A non-inferiority trial comparing 2 days vs. 5 days of terlipressin and ceftriaxone in terms of 5-day rebleeding for patients with acute gastro-esophageal variceal hemorrhage